The traditional 'take-make-waste' model of medical manufacturing is being challenged by researchers who view the environmental footprint of healthcare as a critical engineering problem. For decades, the medical industry has operated under a strict mandate of patient safety and clinical sterility, a
The design flexibility of bioprinted vascular platforms allows for the customization of cell ratios and geometries to meet the specific needs of individual patients. This high level of precision is particularly vital in 2026, as the medical community continues to face the mounting challenge of
Global manufacturers like Nestlé Health Science and Danone are increasingly focusing on the development of savory and plant-based options to meet diverse patient preferences. This strategic pivot comes at a time when the trauma recovery nutrition market is undergoing a significant transformation,
By adopting a flexible modular design, Bayer is engineering a manufacturing environment capable of adapting to the rapid evolution of therapeutic drug requirements. This strategic $2.2 billion commitment to establish a state-of-the-art pharmaceutical campus in New Albany, Ohio, marks a significant
The Italian CDMO sector has seen its export turnover quadruple over the last ten years, signaling a profound shift in the continent’s industrial power balance. This evolution has transformed Italy into the central pillar of the European pharmaceutical landscape, particularly through the excellence
The metabolic fitness of manufactured immune cells is a crucial metric, as exhausted cells lose their ability to persist once injected into a patient. Glioblastoma multiforme remains a relentless adversary in the field of neuro-oncology, characterized by its rapid progression and an almost
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42